As the global leader in Data-Driven Medicine, SOPHiA GENETICS helps healthcare professionals better diagnose and treat cancers and hereditary disorders thanks to complex genomics and radiomics analysis powered by SOPHiA AI. The company achieves its mission of contributing to a more sustainable global healthcare system by providing equal benefits to all users, uniting experts in a gold standard health tech platform, and motiving expert knowledge sharing to enter a new era in healthcare, where the data used to help a patient today will benefit those of tomorrow. Adopted by more than 995 hospitals in 82 countries, SOPHiA has already supported the diagnosis of more than 400,000 patients worldwide.
29.08.2024
Remarkable milestones for three life sciences start-ups (startupticker.ch)
14.05.2024
Revenue growth and $50m debt financing for SOPHiA GENETICS (startupticker.ch)
05.03.2024
Business wind down and take off for listed Swiss startups (startupticker.ch)
02.05.2023
Swiss startups in the spotlight in Turkey, Tokyo and beyond (startupticker.ch)
07.12.2021
Swiss inventions get recognition home and away (startupticker.ch)
25.09.2019
No Jobs
Jurgi Camblong answers questions after SOPHiA GENETICS wins "Jury's special prize" at the PVEI 2018
Tech Tour Growth Forum 2015 Interview with Jurgi Camblong of Sophia Genetics
TEDx Comment interpréter le génôme: Jurgi Camblong
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
The venture business plan competition takes place every year and combines a competition, learning events and contact form in one. It is an initiative of the ETH Zurich, CTI and McKinsey.
CTI Start-up enables entrepreneurs to realize their innovative idea professionally.
In a process of three phases, over forty experienced coaches guide start-up companies on their way to enter the market successfully and attract financing. At the end of the coaching process, the most promising start-up companies have the opportunity to receive the prestigious CTI Start-up ’Label’. In addition, the companies benefit from the wide CTI Start-up network of industry experts, experienced entrepreneurs, business angels, venture capitalists and has access to foundations such as de Vigier, STI, FIT, Gebert, Rüf, etc.
Until today, CTI Start-up reviewed more than 1 800 projects, and awarded over 200 start-up enterprises with the CTI Start-up Label. Over 85% of these companies are still in business and some have shown remarkable growth, which is a sign that CTI Start-up guides them to sustainable success.
CTI also promotes the culture of entrepreneurship at universities, teaching hospitals, technical institutes as well as universities of applied sciences. CTI Entrepreneurship offers workshops to students on how to bring innovation to the market.
Being among the TOP 100 Startups in Switzerland has become a seal of approval for founders, and the TOP 100 Swiss Startup Ranking provides them with the recognition they deserve. As startups cannot appear in the startup ranking for more than five years after incorporation, the TOP 100 Swiss Scale-up Ranking has been introduced. A growth jury is asked to select the TOP 100 Swiss Scale-ups. These companies, aged five up to 10 years, show the greatest potential for further growth and represent the future Swiss unicorns
Website:
www.sophiagenetics.com
Headquarter:
Saint Sulpice
Foundation Date:
March 2011
Technology:
Sectors: